Opiates

This test detects the presence of opiate compounds and their metabolites in urine. The primary targets are morphine and codeine, which are the principal metabolites of natural and semi-synthetic opiates. The test provides a qualitative result indicating whether opiate metabolites are present above the assay cut-off level.

It is important to note that standard opiate immunoassays may not detect synthetic opioids such as methadone, fentanyl, or tramadol, which require specific targeted tests.

Opiate screening is a standard component of workplace, clinical, and forensic drug testing panels. Detection may indicate prescribed opiate use, non-medical use, or exposure from dietary sources such as poppy seeds.

Clinical context, medication history, and confirmatory testing are essential for accurate interpretation, as a positive result does not by itself indicate the specific opiate or the source of exposure.

Testing may be relevant as part of standard workplace drug screening, clinical evaluations, pain management monitoring, substance abuse treatment programmes, or emergency toxicology assessments.

Consult a healthcare professional for guidance on testing protocols and result interpretation, particularly when prescribed opiate medications are involved.